Description
Summary of clinical studies evaluating curcumin formulations for conditions involving inflammasome-driven inflammation, including dosing and outcome data.
Cite This Figure
![Figure 7: Summary of clinical studies evaluating curcumin formulations for conditions involving inflammasome-driven inflammation, including dosing and outcome data.]() > Source: Tarek Benameur et al. "The Effects of Curcumin on Inflammasome: Latest Update.." *Molecules (Basel, Switzerland)*, 2023. PMID: [36677800](https://pubmed.ncbi.nlm.nih.gov/36677800/)
<figure> <img src="" alt="Summary of clinical studies evaluating curcumin formulations for conditions involving inflammasome-driven inflammation, including dosing and outcome data." /> <figcaption>Figure 7. Summary of clinical studies evaluating curcumin formulations for conditions involving inflammasome-driven inflammation, including dosing and outcome data.<br> Source: Tarek Benameur et al. "The Effects of Curcumin on Inflammasome: Latest Update.." <em>Molecules (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36677800/">36677800</a></figcaption> </figure>